Regulatory profile of phenformin with its adverse event in usa and rest of the world

×

Error message

User warning: The following theme is missing from the file system: journalijdr. For information about how to fix this, see the documentation page. in _drupal_trigger_error_with_delayed_logging() (line 1138 of /home2/journalijdr/public_html/includes/bootstrap.inc).

International Journal of Development Research

Volume: 
13
Article ID: 
26577
6 pages
Research Article

Regulatory profile of phenformin with its adverse event in usa and rest of the world

Sachin More, Krutika Sawarkar, Gaurav Dhait and Aditya Shobhane

Abstract: 

Pharmaceutical market is vast growing market as per people need invention, modification and innovation is done in field of pharmaceuticals. As the market grow the safety and efficacy of drug is very important as drugs are consumed by a large number of populations. There has been mega outbreak before in the past time, so avoid that type of outbreak the post marketing studies is very important and should maintain pharmacovigilance data. The regulatory authorities of country should hold the responsibilities for the proper surveillance over the period of time up to particular drug is in market. Regulatory authorities should notify people of country about the ADR or the recalled drug. Just like drug phenformin was in the United States Market for long 20 years in spite of having fatal adverse drug reaction of Ketonuria and lactic acidosis. People should know the importance of aftermarket surveillance, ADR reporting, pharmacovigilance and should be aware about the drug use in day-to-day life.

DOI: 
https://doi.org/10.37118/ijdr.26577.04.2023
Download PDF: